Trastuzumab beta (ABP 980) 是一种曲妥珠单抗 Trastuzumab (HY-P9907) 的生物仿制药。Trastuzumab beta 是一种靶向人表皮生长因子受体 2 (HER2) 的单克隆抗体 (McAb)。 Trastuzumab beta 可用于 HER2 阳性转移性乳腺癌、早期乳腺癌 (EBC) 和转移性胃癌的研究。
| 生物活性 | Trastuzumab beta (ABP 980) is a biosimilar toTrastuzumab(HY-P9907). Trastuzumab beta is a monoclonal antibody (McAb) targeting human epidermal growth factor receptor 2 (HER2). Trastuzumab beta can be used for the research of HER2-positive metastatic breastcancer, early breastcancer(EBC), and metastatic gastriccancer[1]. |
| IC50& Target | |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com